Skip to main content
Market intelligence
ARQTHealthcare

Arcutis Biotherapeutics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 17, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 17, 2026Howard G. WelgusCorporate insiderSale4,731$24.58$116,281
Jun 15, 2026Sue-Jean LinCorporate insiderSale4,946$24.38$120,587
May 11, 2026Latha VairavanSVP Chief Financial OfficerSale435$21.05$9,157